The American Heart Association Heart Failure Summit, Bethesda, April 12, 2017

Pamela N Peterson1,2, Larry A Allen1, Paul A Heidenreich3,4

  • 1Department of Medicine, Denver Health Medical Center, CO (P.N.P.).

Insights

The American Heart Association convened diverse stakeholders to address heart failure (HF) challenges. Key focus areas include early identification, patient tracking, population health, reducing hospitalizations, and promoting self-management for better HF outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • Heart failure (HF) presents a complex and evolving challenge in cardiovascular medicine.
  • A multidisciplinary group convened to address critical gaps in HF care.
  • Improving outcomes for HF patients requires coordinated efforts across various sectors.

Purpose of the Study:

  • To summarize the current state of heart failure (HF).
  • To identify challenges and opportunities in HF identification and treatment.
  • To recommend focused areas for improving HF care and patient outcomes.

Main Methods:

  • Convened a meeting with diverse stakeholders: clinical care organizations, government agencies, researchers, patient advocates, and healthcare partners.
  • Facilitated dialogue and brainstorming sessions.
  • Focused on key topics including HF identification, patient tracking, population health, hospitalization reduction, and self-management.

Main Results:

  • Highlighted the broad engagement of stakeholders invested in HF care improvement.
  • Identified key areas for action: patient identification, post-diagnosis tracking, population health strategies, reducing HF hospitalizations, and promoting self-management.
  • Emphasized the need to close gaps in identifying individuals at risk for HF.

Conclusions:

  • Coordinated efforts are essential to improve identification and treatment of heart failure (HF).
  • Addressing HF requires a comprehensive approach encompassing population health and patient self-management.
  • Focused initiatives are needed to reduce HF-related morbidity, mortality, and hospitalizations.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319